MUREX PHARMACEUTICALS ANNOUNCES JOINT DEVELOPMENT AGREEMENT WITH GENE NETWORK SCIENCES

Murex Pharmaceuticals today announced its joint agreement with Gene Network Sciences (GNS) to develop cancer therapeutics. Murex, a Dallas-based pharmaceutical company, will utilize technology from GNS to create computer-based models that enhance identification and validation of cancer targets.
PipelioneReview.com